These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8791114)

  • 1. Chemoprevention of primary liver cancer.
    Buiatti E
    IARC Sci Publ; 1996; (136):41-3. PubMed ID: 8791114
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
    Koga H
    Cancer; 2003 Aug; 98(4):661-7. PubMed ID: 12910508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of liver cancer: current strategies and future perspectives.
    Moriwaki H
    Int J Clin Oncol; 2002 Feb; 7(1):27-31. PubMed ID: 11942046
    [No Abstract]   [Full Text] [Related]  

  • 4. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
    Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can a vitamin prevent hepatocellular carcinoma?
    Venook AP
    Hepatology; 1997 Jan; 25(1):249-50. PubMed ID: 8985300
    [No Abstract]   [Full Text] [Related]  

  • 6. [Towards a chemoprevention of hepatocellular carcinoma?].
    Ganne-Carrié N; Christidis C; Beaugrand M
    Gastroenterol Clin Biol; 1997; 21(6-7):447-9. PubMed ID: 9295970
    [No Abstract]   [Full Text] [Related]  

  • 7. Oltipraz chemoprevention trial in Qidong, People's Republic of China: unaltered oxidative biomarkers.
    Glintborg B; Weimann A; Kensler TW; Poulsen HE
    Free Radic Biol Med; 2006 Sep; 41(6):1010-4. PubMed ID: 16934685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of China.
    Zhang BC; Zhu YR; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Li YF; Fang X; Yu LY; De Flora S; Jacobson LP; Zarba A; Egner PA; He X; Wang JS; Chen B; Enger CL; Davidson NE; Gordon GB; Gorman MB; Prochaska HJ; Groopman JD; Muñoz A; Kensler TW
    J Cell Biochem Suppl; 1997; 28-29():166-73. PubMed ID: 9589363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where are we in the chemoprevention of hepatocellular carcinoma?
    Lu SC
    Hepatology; 2010 Mar; 51(3):734-6. PubMed ID: 20198627
    [No Abstract]   [Full Text] [Related]  

  • 10. The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver.
    Borbath I; Leclercq I; Moulin P; Sempoux C; Horsmans Y
    Eur J Cancer; 2007 Jul; 43(11):1755-63. PubMed ID: 17582756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aspirin a day: the allure (and distraction) of chemoprevention.
    Levy IG; Pim CP
    J Natl Cancer Inst; 2012 Dec; 104(23):1782-4. PubMed ID: 23197493
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemoprevention of liver cancer by plant polyphenols.
    Stagos D; Amoutzias GD; Matakos A; Spyrou A; Tsatsakis AM; Kouretas D
    Food Chem Toxicol; 2012 Jun; 50(6):2155-70. PubMed ID: 22521445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes.
    Jacobson LP; Zhang BC; Zhu YR; Wang JB; Wu Y; Zhang QN; Yu LY; Qian GS; Kuang SY; Li YF; Fang X; Zarba A; Chen B; Enger C; Davidson NE; Gorman MB; Gordon GB; Prochaska HJ; Egner PA; Groopman JD; Muñoz A; Helzlsouer KJ; Kensler TW
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):257-65. PubMed ID: 9107431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence.
    Siegel AB; El-Serag HB
    Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):493-5. PubMed ID: 23984995
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies for chemoprevention of liver cancer.
    Kensler TW; Egner PA; Wang JB; Zhu YR; Zhang BC; Qian GS; Kuang SY; Gange SJ; Jacobson LP; Muñoz A; Groopman JD
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S58-64. PubMed ID: 12570336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review).
    Kojima S; Okuno M; Matsushima-Nishiwaki R; Friedman SL; Moriwaki H
    Int J Oncol; 2004 Apr; 24(4):797-805. PubMed ID: 15010815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemopreventive activity of a macrofungus Phellinus rimosus against N-nitrosodiethylamine induced hepatocellular carcinoma in rat.
    Ajith TA; Janardhanan KK
    J Exp Ther Oncol; 2006; 5(4):309-21. PubMed ID: 17024971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory function of interferon on hepatocarcinogenesis.
    Yano H
    Oncology; 2008; 75 Suppl 1():22-9. PubMed ID: 19092269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer chemoprevention as adjuvant therapy for hepatocellular carcinoma.
    Okada S
    Jpn J Clin Oncol; 2001 Aug; 31(8):357-8. PubMed ID: 11574626
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need.
    Herberman RB; Pearce HL; Lippman SM; Pyenson BS; Alberts DS
    Cancer Res; 2006 Dec; 66(24):11540-9. PubMed ID: 17158189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.